Safety and effectiveness of MVA-BN vaccination against mpox in at-risk individuals in Germany (SEMVAc and TEMVAc): a combined prospective and retrospective cohort study MVA-BN vaccination was safe and well tolerated. One dose of MVA-BN offered protection against mpox but effectiveness was reduced in people living with HIV. Although randomised controlled trials remain...

#Medsky🧪 #IDsky #publichealth According to @sanderlab.bsky.social via @thelancetinfdis.bsky.social #SEMVAc study demonstrates that the MVA-BN vaccine ( #Imvanexv / #Jynneos) is safe & effective against #mpox, single dose do not sufficiently protect #HIV patient .

www.thelancet.com/journals/lan...